No earnings within 2 weeks of this transaction.
| Insider | Bredt David |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Dec 31, 2025 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jan 5, 2026 |
| Shares Sold | 6,567 |
| Price per Share | $30.05 |
| Total Value | $197,337.69 |
| Shares Owned After | 404,075 |
| Derivative | No |
| Accession Number | 0001193125-26-002470 |
| Document | View SEC Filing |